Bolden Therapeutics
Johnny Page is a Co-Founder and CEO of Bolden Therapeutics. He received his A.B. in Music, Sc.B. in Neuroscience, and Sc.M. in Biotechnology, all from Brown University. He also completed additional entrepreneurship training at MIT in 2018. Johnny leads Bolden’s effort to develop novel compounds to help treat neurological diseases.
This person is not in any teams
Bolden Therapeutics
1 followers
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.